Health Canada / HPFB-regulated. Provincial pharmacy boards (OCP, CPhA) for dispensing. Closest market to the U.S. operating model — a wave-1 launch candidate.
NoTimeRx · Global · Coming 2026
Same medicine. Anywhere.
NoTimeRx is rolling out internationally — same provider-reviewed telemedicine model, adapted for each country's regulator, currency, and pharmacy law. Fourteen launch markets across North America, Africa, Europe, the Middle East, South Asia, East Asia, and Oceania.
Launch markets
14 countries. One platform.
Each market gets a local regulatory wrapper, local currency, local pharmacy partners. The medical model — provider-reviewed, mailed-to-you, refill-managed — is the same everywhere.
COFEPRIS-regulated. Largest Spanish-language market in the launch set; bilingual telemedicine + Mexican-pharmacy fulfillment partnerships in pipeline.
FDA Ghana oversight. Telemedicine partnerships under discussion with mPharma and Eden Health–style local platforms.
MHRA-regulated medicines, GMC-registered prescribers. Mature private telemedicine market — competing on quality of intake, not price.
CBG-MEB approval pathway. High mail-order pharmacy adoption — clean fit for the discreet-shipping model.
AIFA + ASL coordination. National e-prescription (DEMA) integration is the unlock for cross-region delivery.
ANSM-regulated. Doctolib-style booking integration under exploration; pharmacist counselling required at dispense.
BfArM + PEI (biologicals). Versandapotheke channel via DocMorris / ShopApotheke partnerships.
PMDA is the strictest regulator on this list. English-friendly Tokyo / Osaka clinic pilot is our planned entry.
SFDA-regulated. Sexual-health products dispensed under local clinical guidelines; a smaller initial formulary is expected.
DHA (Dubai) + MOHAP (federal) licensing. English-language telehealth is growing fast — a natural early-launch market.
TGA-regulated. Mature digital-health competitors (InstantScripts, Eucalyptus) — we're entering on intake quality and provider continuity.
URPL-regulated. The e-recepta system is one of the most mature in Europe — easy plug-in for cross-EU prescriber workflows.
CDSCO-regulated. Mature e-pharmacy ecosystem (1mg, PharmEasy, Tata 1mg) and a deep domestic generics manufacturing base — strong fit for oral + topical formulary at launch.
MFDS-regulated. Sophisticated dermatology + aesthetics market with strong demand for finasteride, dutasteride, tretinoin, and isotretinoin. Telemedicine legalized permanently in 2023 — a clean regulatory fit for the NoTimeRx model.
Formulary scope
What ships globally vs. U.S.-only.
Some of our flagship products rely on U.S. compounding-pharmacy law (FD&C Act §503A). Those don't cross borders. The rest does, subject to each country's prescribing rules.
Available globally
Where each country's prescribing rules permit.
- Hair loss — oral finasteride / dutasteride, oral minoxidil, standard topical finasteride / minoxidil (Rogaine-equivalent), topical valproate, apremilast foam
- Skincare — tretinoin, tazarotene, isotretinoin (with each country's pregnancy-prevention program), benzoyl peroxide / ciclopirox medicated shampoos
- Eye care — olopatadine, cyclosporine 0.05%, lifitegrast 5%
- Sexual and Reproductive Health — sildenafil, tadalafil (where culturally / legally permitted)
- Oral care — nano-hydroxyapatite toothpastes (cosmetic; broadly available)
- Nootropics — L-theanine, Lion's Mane, Alpha GPC, citicoline, L-tyrosine, beta-ecdysterone (where local supplement law allows)
- Longevity — PEA cream, metformin (Rx), CBD products (where federally legal)
U.S.-only
Compounded under §503A — not exportable.
- Sulfogenz™ — 5% / 10% liposomal minoxidil sulfate (the FolliGenz flagship)
- All peptide blends — BPC-157, TB-500, KPV, GHK-Cu, Thymosin α-1, Epitalon, Selank, Semax, CJC-1295 + Ipamorelin, MOTS-c, AOD-9604
- Methylene Blue troche — compounded mitochondrial therapy
- Compounded combo topicals — FinaGenz + MinoGenz 2-in-1, hormonal scalp stacks at compounding-grade strengths
- Intranasal LDN / Oxytocin — compounded sprays
- PT-141 / Bremelanotide — peptide-based
- Topical estrone / progesterone / spironolactone — at NoTimeRx compounding strengths (commercial-strength alternatives may exist locally)
Waitlist
Be first in your country.
We invite waitlist patients in waves as each country's pharmacy + provider partnerships go live. No card on file, no auto-charge.
Why isn't Sulfogenz™ available outside the U.S.?
Sulfogenz™ (5% liposomal minoxidil sulfate) is compounded by U.S. state-licensed pharmacies under §503A of the FD&C Act. That regulatory pathway doesn't have a direct equivalent in most other countries — and where it does, the bulk drug substance, USP/NF monograph, and certificate-of-analysis chain has to be re-established locally. Same for our other compounded products.
What about peptides — BPC-157, TB-500, GHK-Cu?
None of our peptide blends will be available internationally at launch. Most peptide therapies that exist on the U.S. site are compounded specifically because the underlying API isn't a finished drug anywhere. International equivalents (e.g., Thymosin α-1 as Zadaxin) may exist locally — check with a local provider.
Do I need to live in the country I'm signing up for?
Yes. Each country's prescription is issued by a locally-licensed provider for delivery to a local address. We can't ship a UK prescription to Germany or vice versa.
When will my country actually open?
Wave 1 (waitlist → live): Canada, UAE, Netherlands, UK, Australia. Wave 2: Mexico, Germany, France, Italy, Poland, Ghana, India. Wave 3: Japan, Saudi Arabia. Exact timing depends on partnership and regulatory closure in each market.
Will pricing match the U.S. site?
No. Each market has its own currency, its own pharmacy economics, and its own regulator-driven pricing. We aim for parity in value, not exact price matching.
Do existing U.S. patients get anything in the international markets?
If you're a U.S. patient and travel to a launch country, your existing intake + provider record stays in the U.S. system. You can't refill internationally without a local intake — same as how U.S. providers can't write into another country's pharmacy.